Ethical Dilemmas and Standards Ethical Dilemmas and Standards in - - PowerPoint PPT Presentation

ethical dilemmas and standards ethical dilemmas and
SMART_READER_LITE
LIVE PREVIEW

Ethical Dilemmas and Standards Ethical Dilemmas and Standards in - - PowerPoint PPT Presentation

Ethical Dilemmas and Standards Ethical Dilemmas and Standards in Research with Drug Users in Research with Drug Users Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS cira.med.yale.edu


slide-1
SLIDE 1

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Ethical Dilemmas and Standards Ethical Dilemmas and Standards in Research with Drug Users in Research with Drug Users

Kaveh Khoshnood & Kevin Irwin Yale School of Public Health

UCONN UCONN – – CHIP CHIP March 31, 2005 March 31, 2005

Acknowledgment: NIDA, NIMH, Donaghue Foundation and CIRA

slide-2
SLIDE 2

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Take Home Message (1)

Current ethical principles do not: A) adequately identify ethical dilemmas arising in field-based research with out-of-treatment drug users B) nor do they offer pragmatic guidance on resolving these dilemmas

slide-3
SLIDE 3

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Take Home Message (2)

  • 1. There is a need for the

development of specific ethical guidelines for field-based research involving active drug users in international settings.

  • 2. We must provide incentives and

venues for researchers to document not only their research

  • utcomes but also their research

experiences, particularly regarding ethical issues.

slide-4
SLIDE 4

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Why/How Did we Get Interested in this Issue?

  • Confronted thorny ethical dilemmas in

conducting field based HIV prevention research in US

  • As we expanded our research to

international settings, new ethical issues emerged

slide-5
SLIDE 5

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

What Did We Do?

1) Document our own research experiences Ethical dilemmas created by the criminalization

  • f status behaviors: Case studies from

ethnographic field research with injection drug

  • users. Health Behavior and Education. 2002; 29:

30-42. 2) Applied for funds to investigate this issue further a) Domestic Research Study (Donaghue) b) International Research Study (CIRA)

slide-6
SLIDE 6

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

“Generic” Ethical Dilemmas in Drug Use Research

  • Illegal nature of drug use and related

activities can result in a variety of risks to subjects and staff

  • Stigma attached to illicit drug use
  • Drug Use is a highly personal and

emotionally charged behavior

  • Vulnerability of drug users creates

potential for their exploitation in research

slide-7
SLIDE 7

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Selected Ethical Dilemmas: Study Participants

  • Risk of arrest and incarceration
  • Achieving Informed Consent and

“voluntary participation” under desperate circumstances

  • Rise of unrealistic expectations

from the researchers

  • Unforseeable Challenges resulting

from field-based research

slide-8
SLIDE 8

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Selected Ethical Dilemmas: Study Staff (1)

  • Risk of physical harm or arrest
  • Stigma of working with “Junkies”
  • Assisting participants in procuring
  • r using drugs
  • Risk of relapse for former IDUs
  • Blurring of personal/professional

boundaries

slide-9
SLIDE 9

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Selected Ethical Dilemmas: Study Staff (2)

  • Observing a significant risk behavior

by study participant (unprotected sex, sharing syringes, etc)

  • Learning of study participant’s

intention to hurt someone

  • Damage to social relationships and

social standing of staff in the community due to unanticipated problems in the study

slide-10
SLIDE 10

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Should We Pay Drug Users for Participation in Research?

slide-11
SLIDE 11

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Does paying drug users undermine informed consent?

slide-12
SLIDE 12

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Informed Consent: Coercion or undue influence

“An investigator shall seek consent only under circumstances that provide the prospective subject or representative sufficient opportunity to consider whether or not to participate and that minimize the possibility of coercion or undue influence” (emphasis added)

US Common Rule for Protection of Human Subjects (1991)

slide-13
SLIDE 13

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Does Payment to drug users for participation in research constitute “coercion” or “undue influence”? Is money special?

slide-14
SLIDE 14

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Additional Ethical Challenges in Drug Use Research in International Settings

  • No or little tradition of research with

drug users.

  • No or inexperienced IRBs.
  • No or limited medical (including drug

treatment) and social service resources.

  • Extremely punitive law enforcement

against drug use.

  • Competing agendas of funders,

researchers, participants, local IRBs and partners.

slide-15
SLIDE 15

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Is there any help out there for researchers to resolve these ethical dilemmas?!

slide-16
SLIDE 16

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Overarching Guiding Principles for Ethical Conduct of Research

  • 1. Respect for persons

(ensuring voluntary & informed consent)

  • 2. Beneficence/non-maleficence

(do good, minimize harm)

  • 3. {Distributive} Justice

(fair distribution of benefits & risks)

slide-17
SLIDE 17

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Ethical Guidelines Ethical Guidelines versus versus Research Experience Research Experience

Ethical guidelines provide principles that can guide human subject research, But,

  • What about research experiences? What

actually happened and how were ethical dilemmas resolved?

  • How do we know what worked and what

didn’t work?

slide-18
SLIDE 18

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Don’t Ask, Don’t Tell !

  • Drug Researchers often confront and

deal with thorny ethical issues; however these experiences are rarely reported or made accessible to other colleagues.

  • There are perceived disincentives for

researchers to openly discuss these experiences that could make them vulnerable to reprisals from funders, regulatory agencies or those who find such research objectionable on moral, ideological and political grounds.

slide-19
SLIDE 19

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Expanding the Ethical Discourse (1)

  • What were the researchers’ experiences

with local NGOs, police, government

  • fficials, IRBs and general community?
  • How was the adequacy of informed

consent ensured?

  • How was the material inducement

(incentive) for participation in research determined and negotiated?

slide-20
SLIDE 20

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

Expanding the Ethical Discourse (2)

  • How did the investigators deal with lack
  • f essential social and medical

resources to refer drug users to?

  • What were the programmatic and policy

implications of the research?

  • Were there significant “adverse events”

in the research setting (i.e, local partners, local community) beyond individual research participants?

slide-21
SLIDE 21

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

The Way Forward: Researchers

  • Assemble multidisciplinary teams that

includes ethicists and social scientists.

  • Report and publish research experiences

and best practices, not only outcomes.

  • Develop community consultations in

setting local standards.

  • Build capacity of both US based and

international IRBs.

  • Consider programmatic and policy

implications of your research; before, during and after your study.

slide-22
SLIDE 22

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

The Way Forward: IRBs

  • Seek resources to increase the capacity

to review protocols involving field-based research with active drug users in international settings.

  • Identify and actively recruit individuals

with expertise in this area to serve as permanent or ad-hoc members of your IRBs.

slide-23
SLIDE 23

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

The Way Forward: Funders/ Regulatory agencies

  • Encourage researchers to share their

experiences with thorny ethical challenges with the larger scientific community.

  • Remove disincentives for researchers to
  • penly discuss ethical challenges they

encounter in their work.

  • Provide funding to increase the capacity
  • f both US and international IRBs to

review research protocols involving active drug users.

slide-24
SLIDE 24

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

The Way Forward: Editors/Organizations

  • Create venues (special issue of Journals,

conferences, websites, etc.) for researchers to document their research experiences and discuss the ethical issues encountered and how they responded to or resolved them.

  • Consider the creation of an

International Harm Reduction Research Ethics Committee that can serve as a clearing house and resource to offer technical assistance.

slide-25
SLIDE 25

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

A Call for Transparency

  • Recent attacks on harm reduction
  • riented research by those who oppose

us on ideological and political grounds should not scare us into a defensive posture.

  • Instead we should use this as an
  • pportunity to set the record straight

and state clearly and forcefully that we have nothing to hide and our research is legitimate and worthy of support by public funds.

slide-26
SLIDE 26

Center for Center for Interdisciplinary Interdisciplinary Research on Research on AIDS AIDS

cira.med.yale.edu cira.med.yale.edu

Yale University Yale University School of School of Medicine Medicine

“Promoting and protecting human rights is inextricably linked with promoting and protecting health. Ethics and human rights derive from quite similar, if not identical, core values” Jonathan Mann